ARCHIVES

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

This article is from The Cancer Letter archive.

Vol. 10 No. 12 | March 23, 1984

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

Antman, Clanton begin work at NCI.

December 5, 2003

NCI-Approved Trials Listed

April 28, 2006

President’s Cancer Panel annual report finds barriers in translational research stall progress.

July 8, 2005